199 to present at the 10th ARDD Conference

Uncategorized / By

We are excited to announce that 199 Biotechnologies will be participating in the 10th annual Aging Research and Drug Discovery (ARDD) conference from August 28-September 1, 2023. The ARDD conference, recognized as a global hub for innovations in aging research and therapeutics, has shown year-over-year growth, drawing thousands of participants worldwide. In this year’s gathering, …

199 to present at the 10th ARDD Conference Read More »

$6.5M Seed Funding for Epigenetic Anti-Ageing Therapy

news / By

London-based startup 199 Biotechnologies announced today that it has secured $6.5M (£5.25M) in seed funding from a group of London-based private investors focused on Longevity & Biomedical Innovation. The funding will support the development of their novel therapy that aims to reverse ageing phenotype in cells through epigenetic reprogramming, with the goal of enhancing overall …

$6.5M Seed Funding for Epigenetic Anti-Ageing Therapy Read More »